Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sobol

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Pathologie-Biologie|February 2, 2010
[Genetic testing in the context of the revision of the French law on bioethics]D Bonneau, S Marlin, D Sanlaville, et al.
Cancer|September 11, 2001
Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian womenC M Julian-Reynier, L J Bouchard, D G Evans, et al.
Cancer Research|July 15, 1996
Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancersH Sobol, D Stoppa-Lyonnet, B Bressac-de-Paillerets, et al.
Genomics|October 1, 1990
Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2AR A Norum, R G Lafreniere, L W O'Neal, et al.
Cancer Research|May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisitedF Eisinger, J Jacquemier, C Charpin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Cancer genetics clinics: target population and consultees' expectationsC Julian-Reynier, F Eisinger, F Chabal, et al.
Journal of Medical Genetics|September 1, 1996
Attitudes towards cancer predictive testing and transmission of information to the familyC Julian-Reynier, F Eisinger, P Vennin, et al.
American Journal of Medical Genetics|October 27, 1998
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le CancerL Essioux, C Girodet, O Sinilnikova, et al.
European Journal of Human Genetics : EJHG|January 1, 1996
Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genesE M van Schothorst, J C Jansen, A F Bardoel, et al.
Pathologie-Biologie|April 25, 2006
[Identification and management of hereditary breast-ovarian cancers (2004 update)]F Eisinger, B Bressac, D Castaigne, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Pathologie-Biologie|February 2, 2010
[Genetic testing in the context of the revision of the French law on bioethics]D Bonneau, S Marlin, D Sanlaville, et al.
Cancer|September 11, 2001
Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian womenC M Julian-Reynier, L J Bouchard, D G Evans, et al.
Cancer Research|July 15, 1996
Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancersH Sobol, D Stoppa-Lyonnet, B Bressac-de-Paillerets, et al.
Genomics|October 1, 1990
Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2AR A Norum, R G Lafreniere, L W O'Neal, et al.
Cancer Research|May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisitedF Eisinger, J Jacquemier, C Charpin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Cancer genetics clinics: target population and consultees' expectationsC Julian-Reynier, F Eisinger, F Chabal, et al.
Journal of Medical Genetics|September 1, 1996
Attitudes towards cancer predictive testing and transmission of information to the familyC Julian-Reynier, F Eisinger, P Vennin, et al.
American Journal of Medical Genetics|October 27, 1998
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le CancerL Essioux, C Girodet, O Sinilnikova, et al.
European Journal of Human Genetics : EJHG|January 1, 1996
Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genesE M van Schothorst, J C Jansen, A F Bardoel, et al.
Pathologie-Biologie|April 25, 2006
[Identification and management of hereditary breast-ovarian cancers (2004 update)]F Eisinger, B Bressac, D Castaigne, et al.
Pageof 10